BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34624851)

  • 1. The clinical course and role of surgery in pediatric malignant peripheral nerve sheath tumors: a database study.
    Lu VM; Wang S; Daniels DJ; Spinner RJ; Levi AD; Niazi TN
    J Neurosurg Pediatr; 2022 Jan; 29(1):92-99. PubMed ID: 34624851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofibromatosis-associated malignant peripheral nerve sheath tumors in children have a worse prognosis: A nationwide cohort study.
    Martin E; Coert JH; Flucke UE; Slooff WM; van de Sande MAJ; van Noesel MM; Grünhagen DJ; Wijnen MHWA; Verhoef C
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28138. PubMed ID: 31889416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors.
    Watson KL; Al Sannaa GA; Kivlin CM; Ingram DR; Landers SM; Roland CL; Cormier JN; Hunt KK; Feig BW; Ashleigh Guadagnolo B; Bishop AJ; Wang WL; Slopis JM; McCutcheon IE; Lazar AJ; Torres KE
    J Neurosurg; 2017 Jan; 126(1):319-329. PubMed ID: 27035165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant peripheral nerve sheath tumors of the spine: results of surgical management from a multicenter study.
    Chou D; Bilsky MH; Luzzati A; Fisher CG; Gokaslan ZL; Rhines LD; Dekutoski MB; Fehlings MG; Ghag R; Varga P; Boriani S; Germscheid NM; Reynolds JJ;
    J Neurosurg Spine; 2017 Mar; 26(3):291-298. PubMed ID: 27834629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant peripheral nerve sheath tumors of the eighth cranial nerve arising without prior irradiation.
    Carlson ML; Jacob JT; Habermann EB; Glasgow AE; Raghunathan A; Link MJ
    J Neurosurg; 2016 Nov; 125(5):1120-1129. PubMed ID: 26745487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical management of craniospinal axis malignant peripheral nerve sheath tumors: a single-institution experience and literature review.
    Chowdhury A; Vivanco-Suarez J; Teferi N; Belzer A; Al-Kaylani H; Challa M; Lee S; Buatti JM; Hitchon P
    World J Surg Oncol; 2023 Oct; 21(1):338. PubMed ID: 37880773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome and prognostic factors in pediatric malignant peripheral nerve sheath tumors: An analysis of the European Pediatric Soft Tissue Sarcoma Group (EpSSG) NRSTS-2005 prospective study.
    van Noesel MM; Orbach D; Brennan B; Kelsey A; Zanetti I; de Salvo GL; Gaze MN; Craigie RJ; McHugh K; Francotte N; Collini P; Bisogno G; Casanova M; Ferrari A
    Pediatr Blood Cancer; 2019 Oct; 66(10):e27833. PubMed ID: 31241238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival outcomes of malignant peripheral nerve sheath tumors (MPNSTs) with and without neurofibromatosis type I (NF1): a meta-analysis.
    Lim Z; Gu TY; Tai BC; Puhaindran ME
    World J Surg Oncol; 2024 Jan; 22(1):14. PubMed ID: 38191386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical presentation and long-term outcome of primary spinal intradural malignant peripheral nerve sheath tumors.
    Chen J; Zheng Y; Chen Z; Fan F; Wang Y
    Clin Neurol Neurosurg; 2019 Oct; 185():105484. PubMed ID: 31421588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The implications of intradural extension in paraspinal malignant peripheral nerve sheath tumors: effects on central nervous system metastases and overall survival.
    Gilder HE; Puffer RC; Bydon M; Spinner RJ
    J Neurosurg Spine; 2018 Dec; 29(6):725-728. PubMed ID: 30239270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncologic outcomes of sporadic, neurofibromatosis-associated, and radiation-induced malignant peripheral nerve sheath tumors.
    LaFemina J; Qin LX; Moraco NH; Antonescu CR; Fields RC; Crago AM; Brennan MF; Singer S
    Ann Surg Oncol; 2013 Jan; 20(1):66-72. PubMed ID: 22878618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of resection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis type 1.
    Dunn GP; Spiliopoulos K; Plotkin SR; Hornicek FJ; Harmon DC; Delaney TF; Williams Z
    J Neurosurg; 2013 Jan; 118(1):142-8. PubMed ID: 23101443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and prognosis of distant metastasis in malignant peripheral nerve sheath tumors.
    Xu Y; Xu G; Liu Z; Duan J; Lin Y; Zhu J; Baklaushev VP; Chekhonin VP; Peltzer K; Wang G; Wang X; Zhang C
    Acta Neurochir (Wien); 2021 Feb; 163(2):521-529. PubMed ID: 33219865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nomograms for predicting the overall and cause-specific survival in patients with malignant peripheral nerve sheath tumor: a population-based study.
    Yan P; Huang R; Hu P; Liu F; Zhu X; Hu P; Yin H; Zhang J; Meng T; Huang Z
    J Neurooncol; 2019 Jul; 143(3):495-503. PubMed ID: 31089923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracranial metastasis from a malignant peripheral nerve sheath tumor in a patient with neurofibromatosis type 1: A case study and literature review.
    Griffin S; Witt MC; El Tecle N; Prim M; Hockman J; Schwetye KE; Pierson MJ
    Clin Neurol Neurosurg; 2021 Apr; 203():106540. PubMed ID: 33607580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulated immuno-modulator PD-L1 in malignant peripheral nerve sheath tumors provides a potential biomarker and a therapeutic target.
    Farschtschi S; Kluwe L; Park SJ; Oh SJ; Mah N; Mautner VF; Kurtz A
    Cancer Immunol Immunother; 2020 Jul; 69(7):1307-1313. PubMed ID: 32193699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumors of the peripheral nervous system: analysis of prognostic factors in a series with long-term follow-up and review of the literature.
    Montano N; D'Alessandris QG; D'Ercole M; Lauretti L; Pallini R; Di Bonaventura R; La Rocca G; Bianchi F; Fernandez E
    J Neurosurg; 2016 Aug; 125(2):363-71. PubMed ID: 26636382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fédération Nationale Des Centres de Lutte Contre Le Cancer (FNCLCC) Grading, Margin Status and Tumor Location Associate With Survival Outcomes in Malignant Peripheral Nerve Sheath Tumors.
    Wakeman KM; Zhang QS; Bandhlish A; Cranmer LD; Ricciotti RW; Mantilla JG
    Am J Clin Oncol; 2022 Jan; 45(1):28-35. PubMed ID: 34962906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant peripheral nerve sheath tumors: prognostic impact of rhabdomyoblastic differentiation (malignant triton tumors), neurofibromatosis 1 status and location.
    Kamran SC; Howard SA; Shinagare AB; Krajewski KM; Jagannathan JP; Hornick JL; Ramaiya NH
    Eur J Surg Oncol; 2013 Jan; 39(1):46-52. PubMed ID: 23084090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation-induced and neurofibromatosis-associated malignant peripheral nerve sheath tumors (MPNST) have worse outcomes than sporadic MPNST.
    Miao R; Wang H; Jacobson A; Lietz AP; Choy E; Raskin KA; Schwab JH; Deshpande V; Nielsen GP; DeLaney TF; Cote GM; Hornicek FJ; Chen YE
    Radiother Oncol; 2019 Aug; 137():61-70. PubMed ID: 31078939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.